These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1407599)

  • 21. Drug treatment of multiple sclerosis.
    Rudick RA; Schiffer RB; Herndon RM
    Semin Neurol; 1987 Jun; 7(2):150-9. PubMed ID: 2845549
    [No Abstract]   [Full Text] [Related]  

  • 22. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
    Feldman RG; Kelly-Hayes M; Conomy JP; Foley JM
    Neurology; 1978 Nov; 28(11):1094-8. PubMed ID: 362234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Continuous intrathecal baclofen therapy using an implantable pump system in severe spasticity].
    Braunsdorf WE; Kuhlendahl HD; Volkheimer A; Behrens C; Kleiter K
    Neurochirurgia (Stuttg); 1990 Oct; 33 Suppl 1():16-9. PubMed ID: 2293041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle relaxants in multiple sclerosis.
    Basmajian JV
    Int Disabil Stud; 1987; 9(2):90-1. PubMed ID: 3680109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal L-baclofen for cerebral spasticity: case report.
    Albright AL; Barry MJ; Hoffmann P
    Neurology; 1995 Nov; 45(11):2110-1. PubMed ID: 7501170
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.
    Ochs G; Struppler A; Meyerson BA; Linderoth B; Gybels J; Gardner BP; Teddy P; Jamous A; Weinmann P
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):933-9. PubMed ID: 2487035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spasticity in a child with myelomeningocele treated with continuous intrathecal baclofen.
    Bergenheim AT; Wendelius M; Shahidi S; Larsson E
    Pediatr Neurosurg; 2003 Oct; 39(4):218-21. PubMed ID: 12944705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug therapy: spasticity (second of two parts).
    Young RR; Delwaide PJ
    N Engl J Med; 1981 Jan; 304(2):96-9. PubMed ID: 7003385
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal baclofen and the H-reflex.
    Macdonell RA; Talalla A; Swash M; Grundy D
    J Neurol Neurosurg Psychiatry; 1989 Sep; 52(9):1110-2. PubMed ID: 2795085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrathecal baclofen therapy and management of severe spasticity].
    Naito Y
    Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic intrathecal baclofen administration for control of severe spasticity.
    Lazorthes Y; Sallerin-Caute B; Verdie JC; Bastide R; Carillo JP
    J Neurosurg; 1990 Mar; 72(3):393-402. PubMed ID: 2303874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump.
    Patterson V; Watt M; Byrnes D; Crowe D; Lee A
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):582-5. PubMed ID: 8201328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term intrathecal baclofen treatment in supraspinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):195-207. PubMed ID: 1442218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal baclofen in severe spasticity.
    McLean BN
    Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):262-7. PubMed ID: 8443626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.